A drug-induced pigmentary disorder is an important differential diagnosis to consider when
approaching a patient with hyper-or hypopigmentation. A thorough history including a …

Various types of drug-induced vitiligo-like depigmentation have been reported in recent
years. Commonly implicated drugs include immune checkpoint inhibitors, targeted drugs …

Medications have long been known to cause pigmentary changes of the skin. While this
frequently occurs as post-inflammatory changes of a resolving drug-induced rash …

Abstract Around 10% to 20% of all cases of acquired hyperpigmentation are drug-induced.
The underlying pathogenesis for drug-induced pigmentation includes melanin …

Drug-induced pigmentation accounts for up to 20% of all cases of acquired pigmentation. A
thorough review of medical history and previous and ongoing medications as well as a …

Several medications have been implicated in drug-induced pigmentation, with evidence for
the association primarily derived from case reports. The incidence rates of drug-induced …

Most targeted anticancer therapies induce dermatological toxicities that are often
predominant. In particular, pigmentary changes are frequent and relatively characteristic …

Objectives: Identify the etiology of drug-induced pigmentation. Review the history and
physical exam of a patient with drug-induced pigmentation. Summarize the treatment and …

Background Vitiligo-like depigmentation is a common skin adverse event in patients
receiving immunotherapy for malignant melanoma, but has been rarely reported in patients …

The occurrence of hyperpigmentation during chemotherapy is one of the most frequent
dermatological adverse events observed with these drugs. It may arise with numerous …